New Test Identifies Parkinson's Biomarker with High Accuracy
TL;DR Summary
The Michael J Fox Foundation has announced a breakthrough test that can detect a biomarker for Parkinson's disease with 90% accuracy, which may be able to indicate disease before typical symptoms appear. The test, called the alpha-synuclein seed amplification assay (αSyn-SAA), looks for synuclein pathology and was developed as part of the Parkinson's Progression Markers Initiative (PPMI). The biomarker will allow scientists to define Parkinson's disease biologically, opening up new routes in diagnostics and potential therapies. The study is published in The Lancet Neurology.
- Breakthrough Test Detects Parkinson's Biomarker With 90 Percent Accuracy, Michael J Fox Foundation Announces IFLScience
- Researchers identify a potential new therapeutic target in Parkinson's disease Medical Xpress
- Smartphones and smartwatches may help track Parkinson's in trials... Parkinson's News Today
- A Breakthrough in Parkinson's Disease | American Council on Science and Health American Council on Science and Health
- A new test can pick out Parkinson's disease patients before their symptoms begin Science
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
3 min
vs 4 min read
Condensed
88%
697 → 84 words
Want the full story? Read the original article
Read on IFLScience